Because of the potential high risk of renal biopsy in advanced CKD patients, the level of Klotho promoter hypermethylation in PBLs was measured in this study instead of performing a renal biopsy, considering that it predicts renal Klotho promoter methylation with high sensitivity and specificity (Chen et al., 2013). This evidence concerns the gene KL and chronic kidney disease.